141 related articles for article (PubMed ID: 6640493)
1. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
2. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
3. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic antibodies in preoperative glioma patients: a diagnostic assay.
Phillips JP; Sujatanond M; Martuza RL; Quindlen EA; Wood WC; Kornblith PL; Dohan FC
Acta Neurochir (Wien); 1976; 35(1-3):43-52. PubMed ID: 961503
[TBL] [Abstract][Full Text] [Related]
5. Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen.
Potter VP; Wood WC; Cohen AM; Kornblith PL
J Surg Oncol; 1984 Jul; 26(3):188-93. PubMed ID: 6547496
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
[TBL] [Abstract][Full Text] [Related]
7. Natural antibodies to cell-surface antigens of human astrocytoma.
Pfreundschuh M; Röhrich M; Piotrowski W; Berlit P; Penzholz H
Int J Cancer; 1982 May; 29(5):517-21. PubMed ID: 7095897
[TBL] [Abstract][Full Text] [Related]
8. Tumor specific fluorescent and complement-dependent cytotoxic antibodies in the serum of rats with chemically induced brain gliomas.
Stavrou D; Anzil AP; Elling H
Acta Neuropathol; 1978 Aug; 43(1-2):111-7. PubMed ID: 676675
[TBL] [Abstract][Full Text] [Related]
9. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls.
Fischer U; Struss AK; Hemmer D; Pallasch CP; Steudel WI; Meese E
Clin Exp Immunol; 2001 Nov; 126(2):206-13. PubMed ID: 11703362
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay.
Kornblith PL; Pollock LA; Coakham HB; Quindlen EA; Wood WC
J Neurosurg; 1979 Jul; 51(1):47-52. PubMed ID: 448418
[TBL] [Abstract][Full Text] [Related]
11. [Immunofluorescence microscopy of a malignant glioma with regard to the occurrence and significance of glioma specific antibodies].
Hackenberg P; Koschnike P
Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):206-13. PubMed ID: 7413856
[TBL] [Abstract][Full Text] [Related]
12. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms by which human gliomas may escape cellular immune attack.
Gately MK; Glaser M; McCarron RM; Dick SJ; Dick MD; Mettetal RW; Kornblith PL
Acta Neurochir (Wien); 1982; 64(3-4):175-97. PubMed ID: 6215833
[TBL] [Abstract][Full Text] [Related]
14. The humoral immune response of patients to their gliomas.
Coakham HB; Kornblith PL
Acta Neurochir Suppl (Wien); 1979; 28(2):475-9. PubMed ID: 290238
[No Abstract] [Full Text] [Related]
15. Serologic analysis of nitrosourea-induced rat gliomas.
Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
[TBL] [Abstract][Full Text] [Related]
17. Serologic analysis of human tumor antigens. II. Reactivity of sera from eleven osetogenic sarcoma patients against autologous and allogeneic tumor cells.
Rosenberg SA; Tondreau SC; Shoffner PC; Hyatt C; Brown JM; Thorpe W; Sindelar W
Surgery; 1979 Aug; 86(2):258-65. PubMed ID: 288177
[TBL] [Abstract][Full Text] [Related]
18. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
Holladay FP; Lopez G; De M; Morantz RA; Wood GW
Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
[TBL] [Abstract][Full Text] [Related]
19. Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival.
Jennings MT; Asadourian LL; Jennings VD; Shapiro JR; Thaler HT
J Neurooncol; 1990 Dec; 9(3):265-73. PubMed ID: 2086740
[TBL] [Abstract][Full Text] [Related]
20. Serological analysis of cell surface antigens of malignant human brain tumors.
Pfreundschuh M; Shiku H; Takahashi T; Ueda R; Ransohoff J; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5122-6. PubMed ID: 283420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
